Liver Cancer clinical trials in Iowa

5 actively recruiting liver cancer trials at 9 sites across Iowa.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Academic/Other

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

This phase III trial compares the effect of immunotherapy (IO) with stereotactic body radiation therapy (SBRT) to IO alone in treating patients with liver cancer (hepatocellular cancer) that may have spread from where it first started to n…

Sponsor: NRG Oncology

NCT ID: NCT07166406

Sites in Iowa:

UI Health Care Mission Cancer and Blood - Ankeny Clinic — Ankeny, Iowa
Mercy Cancer Center-West Lakes — Clive, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic — Clive, Iowa
Greater Regional Medical Center — Creston, Iowa
Iowa Methodist Medical Center — Des Moines, Iowa

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with carcinoid syndrome due to well-differenti…

Sponsor: Crinetics Pharmaceuticals Inc.

NCT ID: NCT07087054

Sites in Iowa:

University of Iowa Health Care — Iowa City, Iowa

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to your body bes…

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

NCT ID: NCT05208762

Sites in Iowa:

University of Iowa — Iowa City, Iowa

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in Iowa:

Massive Bio SYNERGY-AI site — Iowa City, Iowa

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Iowa:

Methodist Jennie Edmundson Hospital — Council Bluffs, Iowa
Covenant Medical Center, Inc — Waterloo, Iowa

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20